Bayer AG and GE Healthcare | Notable Market Players in Radiation Dose Management Market


The radiation dose management market is projected to reach US$ 646.87 million by 2028 from US$ 270.32 million in 2021; it is estimated to grow at a CAGR of 13.3% during 2021–2028.

According to our new research study on "Radiation Dose Management Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Service/Software, Medium, and End User," the market is projected to reach US$ 646.87 million by 2028 from US$ 270.32 million in 2021; it is estimated to grow at a CAGR of 13.3% from 2021 to 2028. The report highlights trends prevailing in the market and the factors governing the market growth. Growing concerns related to radiation exposure and rising cancer cases demanding radiation therapy are among the factors driving the overall market growth. However, organizational challenges and benchmarking lack for dose optimization restrain the market growth.

Radiation therapy is an essential branch of medical science. Various diseases are diagnosed and treated through electromagnetic waves. It is used extensively to treat different types of cancer. However, radiation therapy also has side effects. Therefore, monitoring the correct radiation dose is of paramount importance with any radiation-based medical procedure. The radiation dose is the amount of radiation thrown onto the patient. Radiation dose management includes information on radiation dose recording software, real-time staff dose monitoring, regulatory compliance, and dose reduction technologies, including interactive reconstruction software.

Market leaders operating in the market have undertaken various organic growth strategies in the radiation dose management market. The radiation dose management market majorly consists of the players are Bayer AG and GE Healthcare. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers acquisitions, partnership, and collaboration.

Request Sample PDF Brochure -

Based on medium, the radiation dose management market is segmented into computed tomography, radiation and mammography, fluoroscopy and mammography, and other medium. In 2021, the computed tomography segment held the largest share of the market. The segment is likely to maintain its dominance during the forecast period due to the increasing number of CT examinations worldwide and the rising awareness related to radiation dose exposure. Moreover, the same segment is expected to register the highest CAGR during the forecast period.

Nov’21  Product News   

FUJIFILM Holdings Corporation showcased advancements to its Synapse Enterprise Imaging portfolio at the 2021 Radiological Society of North America (RSNA) conference. The advancements have helped the company to drive the cross-departmental collaboration, workflow efficiency and more-informed clinical decision making.

Aug’21  Product News   

GE Healthcare announced the installation of its latest version of the DoseWatch contrast and radiation monitoring software by Affidea. They further announced, Affidea's centers in Hungary are utilizing version 3.2 of GE's DoseWatch software, along with a new business intelligence tool that permits enhanced monitoring of dosing.

July’21  Product News   

FUJIFILM Holdings Corporation announced the selection of its next-generation Synapse Enterprise Information System (EIS) by one of the country’s largest radiology groups, US Radiology Specialists to drive efficient and high-quality patient care across its network.

May’21Company News

Novarad Corporation has been honored with Best New Radiology Solution award in the fifth annual MedTech Breakthrough Awards program organized by MedTech Breakthrough for its COVID-19 AI Diagnostic Assistant. In partnership with Intel Corp. and leveraging Azure, Microsoft’s cloud computing service, Novarad provides free use of the Diagnostic Assistant for the detection of COVID-19 from CT scans.

Access Full Report –

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us :
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi


Phone: +1-646-491-9876



64 Blog posts